Immunity to COVID-19 and issues of screening for SARS-Cov-2 antibodies

About authors

Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Nikolay A. Mayanskiy
Ostrovityanova, 1, Moscow, 117997; moc.liamg@yalokin.yiksnayam

Received: 2020-06-01 Accepted: 2020-06-15 Published online: 2020-06-23

This paper briefly presents the known data on the immune response to SARS-CoV-2, and also analyzes the possibilities and limitations of serological testing for antibodies that should be accounted for when planning population studies and interpreting their results.